Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor, Hepatitis C Virus NS5A Inhibitor, Hepatitis C Virus NS3/4A Protease Inhibitor
WHO अत्यावश्यक औषधि EML खण्ड: Pangenotypic direct-acting antiviral combinations
यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।
RISK OF HEPATITIS B VIRUS REACTIVATION IN PATIENTS COINFECTED WITH HCV AND HBV Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with VOSEVI.
Nepal brand names not included: no licence-safe source.
is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have: genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor. genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.
The following serious adverse reactions are described below and elsewhere in labeling: Serious Symptomatic Bradycardia When Coadministered with Amiodarone. The most common adverse reactions (incidence greater than or equal to 10%, all grades) observed with treatment with VOSEVI for 12 weeks were headache, fatigue, diarrhea, and nausea.
is contraindicated with rifampin. Coadministration with rifampin.
Pregnancy (label summary): Risk Summary No adequate human data are available to establish whether or not VOSEVI poses a risk to pregnancy outcomes.
What is Sofosbuvir used for?
is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have: genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor.
What are the side effects of Sofosbuvir?
The following serious adverse reactions are described below and elsewhere in labeling: Serious Symptomatic Bradycardia When Coadministered with Amiodarone. The most common adverse reactions (incidence greater than or equal to 10%, all grades) observed with treatment with VOSEVI for 12 weeks were headache, fatigue,...
Who should not take Sofosbuvir?
is contraindicated with rifampin. Coadministration with rifampin.
Does Sofosbuvir have a boxed warning?
RISK OF HEPATITIS B VIRUS REACTIVATION IN PATIENTS COINFECTED WITH HCV AND HBV Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with VOSEVI.
Can I take Sofosbuvir in pregnancy or while breastfeeding?
Pregnancy (label summary): Risk Summary No adequate human data are available to establish whether or not VOSEVI poses a risk to pregnancy outcomes.
What is the dose of Sofosbuvir?
Not provided here. Ask a doctor or pharmacist.
Sofosbuvir के हो?
Sofosbuvir is used for: is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have: genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor. ge…
Sofosbuvir का साइड इफेक्ट के हुन्?
The following serious adverse reactions are described below and elsewhere in labeling: Serious Symptomatic Bradycardia When Coadministered with Amiodarone. The most common adverse reactions (incidence greater than or equal to 10%, all grades) observed with treatment with VOSEVI for 12 weeks were headache, fatigue, d…
स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm